2018 Innovation to Commercialization (I2C) Kate Wilczak Coordinator, Research Competitions

Transcription

1 2018 Innovation to Commercialization (I2C) Kate Wilczak Coordinator, Research Competitions

2 Presentation Agenda Insights from a past I2C Award recipient Program Objectives Award Amount and Duration Eligibility Requirements Technological Readiness Competition Partners Phase II - Match Funding Budget and eligible expenses Mitacs Accelerate partnership Key Competition Dates How to Apply Evaluation Criteria Contact Information 2

3 Insights from a 2017 I2C Award Recipient Dr. ROBERT BRITTON 2017 Innovation to Commercialization Award Recipient Professor Department of Chemistry Simon Fraser University Project Title: Novel 18F-Fluorinated Amino Acids as Oncological PET radiotracers 3

4 Purpose of the I2C Competition The MSFHR Innovation to Commercialization (I2C) award supports researchers to advance their discoveries or inventions that can result in products or technologies that can improve health outcomes, benefit society, and help enrich the health innovation ecosystem in BC. 4

5 Program Objectives Support researchers to enhance and strengthen technology and product maturity toward market usability Increase the potential real-world use and commercial viability of researchers discoveries Support talent development and build capacity for translational research in BC Facilitate interaction between partners and researchers to provide opportunities for investment in commercializable IP 5

6 Award Amount & Duration Phase I: 2 years $150,000/year MSFHR Budget envelope: $1,350,000 Phase II: 2 years Up to $75,000/year from MSFHR Up to $75,000/year in matched funds from partner MSFHR Partner Applicant 6

7 Who is eligible to apply? The applicant must hold an appointment at a BC university, health authority or research institute that has a memorandum of understanding with MSFHR. The applicant must conduct research with a clear link to human health The bulk of the proposed research and commercialization activities must be conducted in BC The IP that provides the basis of the application must: Be at or past active research and development for proof-ofprinciple (TRL3) Not be past the level of a successfully-demonstrated product or technology (i.e. prototype, final formulation, etc.) (TRL6) Have been subjected to an initial IP assessment by a technology transfer office, or equivalent 7

8 Technological Readiness Level TRL 1 TRL 2 TRL 3 TRL 4 TRL 5 TRL 6 TRL 7 TRL 8 TRL 9 Description Basic principles observed and reported Technology concept and/or practical applications invented Active research and development for concept validation (proof-of-principle) Validation of technology in a laboratory setting Validation of technology in a relevant environment Demonstration of technology in a relevant environment (prototype) Prototype demonstrated in an operational environment Technology is proven to work through test and demonstration Actual application of technology in its final form ready for commercialization 8

9 Intellectual Property Assessment Form The IP assessment form must be completed jointly by the applicant and an institutional technology transfer office, or equivalent. List all inventors of the IP and proportion of inventorship in % Description of the IP presented in the application: Intended purpose Level of commercial readiness Potential impact on the health of British Columbians and/or the BC health system Information on the status of the IP: optioned, licensed, sold or assigned to any party other than the academic institution and the applicant; or subject to an agreement with a foreign institution or company. Ownership of the IP (within or outside Canada) 9

10 MSFHR s Claim on IP MSFHR claims no rights of ownership to the intellectual property associated with this funding opportunity. MSFHR requires any intellectual property created or developed within the project supported by the I2C award be exploited in a way that maximizes benefits to the BC health system and the health of British Columbians 10

11 Competition Partners By partnering on our competitions, MSFHR and our partners are able to increase the total number of applications funded by the I2C Program. Partnered awards have the added benefit of offering researchers the opportunity to develop relationships with partners and their community of stakeholders. Process: Applicants interested in partnered awards are encouraged to to register your interest for a partnered award and indicate how your research aligns with partner areas of interest. MSFHR uses keywords provided by the partners to identify applications that may be relevant to and align with the partners area of interest. 11

12 Competition Partners Cont d Applications that fulfill the funding criteria for both MSFHR and a partner organization may be eligible for a partnered I2C award. Only those applications that receive an MSFHR peer review rating of 3.8 or above will be considered for such an award. Applicants are free to secure additional resources when applying for Phase I of the program to strengthen resources and accelerate progress. This is not mandatory. Any additional cash or in-kind support secured by the applicant from these partners need to be listed and confirmed in a signed letter of support. 12

13 Phase II Match Funding Match funding is a mandatory requirement for renewal of the I2C award. MSFHR will match funds 1:1 up to a maximum amount of $75,000/annum for two years with eligible partners. Eligible partners are those who provide support from non-bc government sources. Up to 25 percent of partner contributions can be in the form of inkind support. Remaining 75 percent must be in the form of a cash contribution. 13

14 Phase II - Renewal Phase II is not an automatic renewal of Phase I: Award recipients will be invited to apply for award renewal for an additional two years of support Funding support for these additional two years is contingent upon a successful review of a renewal application Applicants must have a partner willing to match resources Applications for renewal will be evaluated by an external review panel An unsatisfactory evaluation may result in the denial of further funding 14

15 I2C Program Budget MSFHR funds may be used to support any of the following: Buy-out time Stipend and salary of trainees, research assistants, research technicians working directly with the I2C award research Eligible expenses related to feasibility research and implementation of the commercialization plan for specific IP Salary and benefits for the award recipient Travel for collaborative purposes 15

16 Conflict of Interest MSFHR recognizes that in the field of translational health research, researchers may be involved in private sector enterprises that work with them to advance discoveries towards commercialization. A conflict of interest may arise if the applicant: 1. Has an ownership position within the partner organization 2. Is employed by the partner organization in any role, whether salaried or not 3. Is a member on a governing board of the partner organization 4. Is related to a person who controls, or who is a member of a governing board that controls the partner organization If the applicant is subject to one or more of the above instances, the applicant must declare all conflicts of interest and describe how these will be managed. 16

17 Mitacs Accelerate Partnership New this year, MSFHR and Mitacs are partnering to provide an opportunity for interested I2C applicants to also apply for Mitacs Accelerate internship funds. Mitacs Accelerate grants support collaborative research between research faculty and a graduate student or postdoctoral intern. Funding for internships starts at $15,000 per 4-month segment. I2C applicants interested in applying for a Mitacs Accelerate grant for their I2C project can indicate interest on the LOI. Applicants must contact the Mitacs Business Development office to receive an Accelerate application. Part 1 of the Mitacs applications are adjudicated by the MSFHR review panel. 17

18 2018 I2C Competition - Key Dates Stages in Competition Cycle Letter of Intent Deadline Full Application Deadline Target Date February 16, :30 p.m. PT April 3, :30 p.m. PT Anticipated notice of funding decision Late June 2018 Anticipated start of funding August 1,

19 Preparing for your application Be aware of the internal deadlines at your host institution Communicate with your department head (or equivalent) and dean (if applicable) well in advance of your host institution s internal deadline Communicate with any researcher and research-user co-applicants (if applicable) to let them know of the tasks they must complete All third parties must have an MSFHR ApplyNet account to complete their forms. Communicate with your host institution s technology transfer office. You will need to complete an IP Assessment with them at the Full Application stage. Communicate with collaborator(s) and partner(s) (if applicable) if you plan to attach support letters at the Full Application stage. 19

20 20 Application Process Flow

21 Letter of Intent Deadline: February 16, 2018 To start an LOI, log onto the MSFHR ApplyNet and click on the 2018 Innovation to Commercialization (I2C) funding opportunity. Sections of the LOI: Contact information Host Institution** Research Location Project Information Keywords Third Party information Additional Information Career interruptions MSFHR reviews Letters of Intent within two business days of the application deadline Approved LOIs are given access to the Full Application ** As soon as they decide to submit an application, applicants should communicate with their host institution to verify if they are the appropriate host institution. 21

22 Full Application Deadline: April 3, 2018 If LOIs are approved for full application, log into MSFHR ApplyNet and click on Complete Full Application (I2C) opportunity. Sections of the Application: Contact information Host Institution Research Location Project Information Keywords Third Party information Additional Information Uploads Some text boxes will be pre-populated with text entered in the LOI. Uploads: MSFHR CCV (last five years only) Pubs, patents & intellectual property Research & Commercialization Plans Budget Intellectual Property Assessment Form Mitacs Accelerate Application, Part 1 (if applicable) Letters of support from Collaborators and Partners (if applicable) 22

23 What are Reviewers looking for? Three main evaluation categories: Track Record (20%) scientific productivity academic achievements experience in proposed area of research (last five years only) Research Plan (40%) feasibility outcomes originality impact budget justification collaborators (if applicable) timeline with go/no-go milestones Commercialization Plan (40%) feasibility expected milestones and deliverables relevance to research plan description of patenting strategies (if applicable), market evaluation, prior art, etc. 23

24 Contact Information For questions regarding the application and submission process, please contact: Kate Wilczak Coordinator, Research Competitions For more information about the MSFHR ApplyNet system or help with login information, please contact: MSFHR Help Desk For questions about the Mitacs Accelerate application, please contact your regional Mitacs business development office. Regional contacts are found here: 24

25 25